Alloimmunization is an adverse consequence of exposition to red blood cell antigens through transfusion, pregnancy, or transplantation. Alloimmunization to red cell antigens creates problem not only in immunohematological testing but also causes difficulty in finding compatible blood for those patients who develop multiple alloantibodies. Moreover, the development of multiple alloantibodies can significantly complicate transfusion therapy and/or provokes hemolytic transfusion reactions, the severity of which can vary from mild to extremely severe. We are presenting an interesting case with multiple alloantibodies. Patient's samples were investigated for antibody screening using commercially available three cell panels, and the antibody was ...
Background: Blood transfusion usually results in production of alloantibody against one or more fore...
Allogenic blood transfusion has potential effect to trigger the formation of alloantibody in the rec...
Background: Appropriate and regular red cell transfusion remains the main treatment of choice for a ...
Alloimmunization is a detrimental effect of transfusion therapy which makes availability of compatib...
Background: It is well-known that alloimmunization to red blood cell antigens resulting from the gen...
The focus of transfusion services is now shifting toward the prevention of alloimmunization and dela...
In this case report, we provide evidence for the possibility of red blood cell alloimmunization afte...
Routinely, Immunohematology Reference Testing Center receives samples with blood group discrepancy, ...
Background: To study the frequency and specificity of various red cell alloantibodies in multi- tran...
Allogenic blood transfusion has potential effect to trigger the formation of alloantibody in the rec...
This study aimed at determining the presence and type of specific antibodies among multitransfused o...
Introduction: The development of alloantibodies is a major problem among thalassemia major individua...
Background: Thalassemia is a common hemoglobin disorder in Iran and one of the major public health ...
Background: Unexpected red blood cell alloantibodies can cause hemolytic transfusion reactions. In t...
Background: The large diversity of red blood cell antigens favors, especially in multi-transfused pa...
Background: Blood transfusion usually results in production of alloantibody against one or more fore...
Allogenic blood transfusion has potential effect to trigger the formation of alloantibody in the rec...
Background: Appropriate and regular red cell transfusion remains the main treatment of choice for a ...
Alloimmunization is a detrimental effect of transfusion therapy which makes availability of compatib...
Background: It is well-known that alloimmunization to red blood cell antigens resulting from the gen...
The focus of transfusion services is now shifting toward the prevention of alloimmunization and dela...
In this case report, we provide evidence for the possibility of red blood cell alloimmunization afte...
Routinely, Immunohematology Reference Testing Center receives samples with blood group discrepancy, ...
Background: To study the frequency and specificity of various red cell alloantibodies in multi- tran...
Allogenic blood transfusion has potential effect to trigger the formation of alloantibody in the rec...
This study aimed at determining the presence and type of specific antibodies among multitransfused o...
Introduction: The development of alloantibodies is a major problem among thalassemia major individua...
Background: Thalassemia is a common hemoglobin disorder in Iran and one of the major public health ...
Background: Unexpected red blood cell alloantibodies can cause hemolytic transfusion reactions. In t...
Background: The large diversity of red blood cell antigens favors, especially in multi-transfused pa...
Background: Blood transfusion usually results in production of alloantibody against one or more fore...
Allogenic blood transfusion has potential effect to trigger the formation of alloantibody in the rec...
Background: Appropriate and regular red cell transfusion remains the main treatment of choice for a ...